Similarly to breast cancer, in these tumors, SIRT7 inhibits migration and metastasis formation by deacetylating and inhibiting SMAD4, thus reducing EMT (Fig. 8F and Table 1) [94]. Here, SMAD4 is linked to breast carcinoma.